Hyperthyroid Drugs Linked to Risk of Birth Defects

Mothers taking propylthiouracil (PTU) or methimazole (MMI) early in pregnancy were found to have a higher risk of birth defects in infants
Oct. 21, 2013

Two common drugs for treating hyperthyroidism were linked to birth defects when used in early pregnancy, though they have differing effects, researchers said. In an analysis of Danish national data, infants born to mothers taking propylthiouracil (PTU) early in pregnancy had about a 50% higher risk of birth defects, and those taking methimazole (MMI) had a 75% greater risk than children born to women in the general population not taking the drug, Peter Laurberg, MD, of Aalborg University Hospital in Denmark, and colleagues reported at the Amerian Thyroid Association meeting. Read the full story

Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates